Effect of atenolol and diltiazem on heart period variability in normal persons

Department of Medicine, School of Public Health, Columbia University, New York, New York 10032.

Several time and frequency domain measures of heart period variability are reduced 1 to 2 weeks after myocardial infarction, and a reduced standard deviation of normal RR intervals over a 24 h period (SDNN) is associated with increased mortality. The predictive accuracy of heart period variability may be reduced by drugs used to treat patients after myocardial infarction. Accordingly, a randomized, three period, placebo-controlled, crossover (Latin square) design was used to determine the effect of atenolol and diltiazem on time and frequency measures of heart period variability calculated from 24 h continuous electrocardiographic recordings during treatment with atenolol, diltiazem and placebo in 18 normal volunteers. During atenolol treatment, the 24 h average normal RR (NN) interval increased 24% (p less than 0.001). The three measures of tonic vagal activity were significantly increased (p less than 0.001) during atenolol treatment: percent of successive normal RR intervals greater than 50 ms = 69%, root mean square successive difference of normal RR intervals = 61% and high frequency power in the heart period power spectrum = 84%. Low frequency power also increased 45% (p less than 0.01), indicating that this variable also is an indicator of tonic vagal activity over 24 h. Diltiazem had no significant effect on the 24 h average NN interval or on any measure of heart period variability. The decreased mortality rate after myocardial infarction associated with beta-adrenergic blocker but not calcium channel blocker therapy may be attributed in part to an increase in vagal tone caused by beta-blockers.

This article has been cited by other articles:

				C. Cogliati, S. Colombo, T. G. Ruscone, D. Gruosso, A. Porta, N. Montano, A. Malliani, and R. Furlan Acute {beta}-Blockade Increases Muscle Sympathetic Activity and Modifies Its Frequency Distribution Circulation, November 2, 2004; 110(18): 2786 - 2791. [Abstract] [Full Text] [PDF]

				L. Fauchier, D. Babuty, A. Melin, P. Bonnet, P. Cosnay, and J. P. Fauchier Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances Eur J Heart Fail, March 1, 2004; 6(2): 181 - 185. [Abstract] [Full Text] [PDF]

				H.-N. Shen, L.-Y. Lin, K.-Y. Chen, P.-H. Kuo, C.-J. Yu, H.-D. Wu, and P.-C. Yang Changes of Heart Rate Variability During Ventilator Weaning Chest, April 1, 2003; 123(4): 1222 - 1228. [Abstract] [Full Text] [PDF]

				L Forslund, I Bjorkander, M Ericson, C Held, T Kahan, N Rehnqvist, and P Hjemdahl Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris Heart, May 1, 2002; 87(5): 415 - 422. [Abstract] [Full Text] [PDF]

				J. Burggraaf, J. H. M. Tulen, S. Lalezari, R. C. Schoemaker, P. H. E. M. De Meyer, A. E. Meinders, A. F. Cohen, and H. Pijl Sympathovagal imbalance in hyperthyroidism Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E190 - E195. [Abstract] [Full Text] [PDF]

				J D Schipke and M Pelzer Effect of immersion, submersion, and scuba diving on heart rate variability Br. J. Sports Med., June 1, 2001; 35(3): 174 - 180. [Abstract] [Full Text] [PDF]

				J. T. Bigger Jr and T. El-Sherif Polyunsaturated Fatty Acids and Cardiovascular Events: A Fish Tale Circulation, February 6, 2001; 103(5): 623 - 625. [Full Text] [PDF]

				A. Mortara, M. T. La Rovere, G. D. Pinna, R. Maestri, S. Capomolla, and F. Cobelli Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1612 - 1618. [Abstract] [Full Text] [PDF]

				A. Stahle, R. Nordlander, and L. Bergfeldt Aerobic group training improves exercise capacity and heart rate variability in elderly patients with a recent coronary event. A randomized controlled study Eur. Heart J., November 2, 1999; 20(22): 1638 - 1646. [Abstract] [PDF]

				F. Weber, H. Schneider, T. von Arnim, and W. Urbaszek Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris: Influence of drug therapy and prognostic value Eur. Heart J., January 1, 1999; 20(1): 38 - 50. [Abstract] [PDF]

				M. V. Kamath, S. Hollerbach, A. Bajwa, E. L. Fallen, A. R.M. Upton, and G. Tougas Neurocardiac and cerebral responses evoked by esophageal vago-afferent stimulation in humans: effect of varying intensities Cardiovasc Res, December 1, 1998; 40(3): 591 - 599. [Abstract] [Full Text] [PDF]

				N. L. Smith, G. E. Reiber, B. M. Psaty, S. R. Heckbert, D. S. Siscovick, J. L. Ritchie, N. R. Every, and T. D. Koepsell Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1305 - 1311. [Abstract] [Full Text] [PDF]

				C. W. Hogue Jr, P. P. Domitrovich, P. K. Stein, G. D. Despotis, L. Re, R. B. Schuessler, R. E. Kleiger, and J. N. Rottman RR Interval Dynamics Before Atrial Fibrillation in Patients After Coronary Artery Bypass Graft Surgery Circulation, August 4, 1998; 98(5): 429 - 434. [Abstract] [Full Text] [PDF]

				M. V. Hojgaard, N.-H. Holstein-Rathlou, E. Agner, and J. K. Kanters Dynamics of spectral components of heart rate variability during changes in autonomic balance Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H213 - H219. [Abstract] [Full Text] [PDF]

				D. M. Bloomfield, S. Zweibel, J. T. Bigger Jr., and R. C. Steinman R-R variability detects increases in vagal modulation with phenylephrine infusion Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1761 - H1766. [Abstract] [Full Text] [PDF]

				A Kardos, V Long, J Bryant, J Singh, P Sleight, and B Casadei Lipophilic versus hydrophilic beta 1 blockers and the cardiac sympatho-vagal balance during stress and daily activity in patients after acute myocardial infarction Heart, February 1, 1998; 79(2): 153 - 160. [Abstract] [Full Text]

				A. Birand, G. Z. Kudaiberdieva, T. A. Batyraliev, F. Akgul, and A. Usal Effects of Trimetazidine on Heart Rate Variability and Left Ventricular Systolic Performance in Patients with Coronary Artery Disease After Percutaneous Transluminal Angioplasty Angiology, May 1, 1997; 48(5): 413 - 422. [Abstract] [PDF]

				N. Singh, D. Mironov, P. W. Armstrong, A. M. Ross, and A. Langer Heart Rate Variability Assessment Early After Acute Myocardial Infarction : Pathophysiological and Prognostic Correlates Circulation, April 1, 1996; 93(7): 1388 - 1395. [Abstract] [Full Text]

				K. Kumagai, H. Suzuki, M. Ichikawa, M. Jimbo, M. Nishizawa, M. Ryuzaki, and T. Saruta Comparison of Early and Late Start of Antihypertensive Agents and Baroreceptor Reflexes Hypertension, February 1, 1996; 27(2): 209 - 218. [Abstract] [Full Text]

				Y. S. Tuininga, H. J.G.M. Crijns, J. Brouwer, M. P. van den Berg, A. J. Man in't Veld, G. Mulder, and K.I. Lie Evaluation of Importance of Central Effects of Atenolol and Metoprolol Measured by Heart Rate Variability During Mental Performance Tasks, Physical Exercise, and Daily Life in Stable Postinfarct Patients Circulation, December 15, 1995; 92(12): 3415 - 3423. [Abstract] [Full Text]